Slide 1: Q1 2025 Results Presentation
• Q1 2025 RESULTS PRESENTATION • May 15th, 2025
Slide 2: Executive Summary
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Executive Summary Q1 2025 key trends and figures Q1 2025 Sales at €107.2m, +3.2% vs. Q1 2024 €25.8m adjusted EBITDA in Q1 2025, +6.1% vs. previous year, with 24
Slide 3: Q1 2025 Results At-a-Glance
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Q1 2025 Results At-a-Glance Growing revenues and profitability, leverage at 2.5x post acquisition SALES Adjusted EBITDA and % Net Financial Position and Leverag
Slide 4: Sales vs. Q1 2024
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Sales – Q1 2025 vs. Q1 2024 +3.2% YoY growth, supported by M&A contribution and pricing SALES – Q1 2024 TO Q1 2025 BRIDGE €m • +3.2% growth vs. Q1 2024, support
Slide 5: Sales Performance by Division
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Sales – Q1 2025 Performance by Division New segment reporting in Healthcare & Life Sciences Healthcare & Life Sciences Safety Energy & Mobility €m €m €m +6.1% +
Slide 6: Adj. EBITDA vs. Q1 2024
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Adj. EBITDA – Q1 2025 vs. Q1 2024 +6.2% YoY growth ADJ. EBITDA – Q1 2024 TO Q1 2025 BRIDGE €m 23.4% ADJUSTED EBITDA % 24.1% 70bps of margin accretion • Q1 2025
Slide 7: Adj. Net Income vs. Q1 2024
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Adj. Net Income – Q1 2025 vs. Q1 2024 +21.6% YoY growth excl. FX impact Adj. Net Income Adj. Net Income Excl. FX Gains/Losses €m €m 13.0 +21.6% 12.0 9.9 12.5% 1
Slide 8: Net Financial Position vs. FY 2024
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Net Financial Position – Q1 2025 vs. FY 2024 Leverage at 2.5x post Whole Blood acquisition NET FINANCIAL POSITION – FY 2024 TO Q1 2025 BRIDGE €m 2.1x LEVERAGE R
Slide 9: Update on Tariff and FY 2025 Guidance
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Update on Tariff and FY 2025 Guidance Limited impact from the new tariff, FY 2025 guidance confirmed • The new tariff environment represents an opportunity for
Slide 10: Q1 2025 Results – Financial Statements: P&L
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Q1 2025 Results – Financial Statements Q1 2024 and Q1 2025 P&L – Statutory Adjusted View of which Q1 2024 of which Q1 2025 €m Q1 2024 % Q1 2025 % non-recurring
Slide 11: Q1 2025 Results – Financial Statements: Balance Sheet
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Q1 2025 Results – Financial Statements Reclassified Balance Sheet - FY 2024 – Q1 2025 As of As of €m 31-Dec-2024 31-Mar-2025 Net intangible fixed assets 472.9 4
Slide 12: Q1 2025 Results – Financial Statements: Cash Flow
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Q1 2025 Results – Financial Statements Cash Flow Statement - Q1 2024 – Q1 2025 €m Q1 2024 Q1 2025 Pre-tax result 12.5 2.5 Amortisation, depreciation and writedo
Slide 13: Disclaimer
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Disclaimer Pursuant to art. 154-bis, paragraph 2, of the Italian Unified Financial Act of February 24, 1998, the executive in charge of preparing the corporate